NEW DELHI — India is reporting 31,521 newly confirmed coronavirus infections in the past 24 hours, dropping to just over a third of the peak level seen in mid-September.
India’s single-day cases have remained below 50,000 for more than a month.
The health ministry also reported 412 deaths Thursday, raising India’s total fatalities to 141,772.
India’s health ministry says some coronavirus vaccines are likely to receive licenses in the next few weeks. It has outlined an initial plan to immunize 300 million people.
Three vaccine companies have applied for early approval in India: Serum Institute of India, which has been licensed to manufacture the AstraZeneca vaccine, Pfizer Inc., and Indian manufacturer Bharat Biotech.
About 50% of Americans will take the new coronavirus vaccine, according to The Associated Press-NORC Center for Public Affairs Research survey. About 25% of U.S. adults aren’t sure if they want to get vaccinated, taking a wait and see approach.
Canada health regulators approve Pfizer’s vaccine, days ahead of possible approval in the United States. Health Canada says 249,000 doses of the vaccine made by U.S. drugmaker Pfizer and Germany’s BioNTech will arrive this month and be administered within days.